OAM
UTMD icon

Oxford Asset Management’s Utah Medical Products UTMD Stock Holding History

Oxford Asset Management’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,857
Closed -$308K – 1257
2019
Q4 		$308K Sell
2,857
-2,367
-45% -$240K 0.01% 1428
2019
Q3 		$501K Sell
5,224
-887
-15% -$82.4K 0.01% 1263
2019
Q2 		$585K Sell
6,111
-1,101
-15% -$92.7K 0.01% 1208
2019
Q1 		$636K Sell
7,212
-6,685
-48% -$588K 0.01% 1117
2018
Q4 		$1.16M Sell
13,897
-4,286
-24% -$377K 0.03% 791
2018
Q3 		$1.71M Buy
18,183
+3,461
+24% +$331K 0.04% 753
2018
Q2 		$1.66M Buy
14,722
+1,461
+11% +$153K 0.03% 771
2018
Q1 		$1.31M Buy
13,261
+912
+7% +$81.4K 0.03% 802
2017
Q4 		$977K Sell
12,349
-1,432
-10% -$112K 0.02% 946
2017
Q3 		$1.03M Buy
13,781
+10,100
+274% +$726K 0.02% 927
2017
Q2 		$267K Buy
+3,681
New +$242K 0.01% 1289

Other funds holding UTMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $67.5B AUM 28.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Oxford Asset Management's UTMD Position: Q1 2020 in Review

Oxford Asset Management sold out of Utah Medical Products (UTMD) in Q1 2020, closing a stake of 2,857 shares — an estimated $308K sold.

Oxford Asset Management first reported a position in UTMD in Q2 2017 and held it in 11 quarters. The position peaked at $1.71M in Q3 2018. 90 funds tracked by Wall St. Rank hold UTMD as of Q1 2020.

  • Oxford Asset Management reported no remaining Utah Medical Products position as of Q1 2020 after selling out during the quarter.
  • Oxford Asset Management sold 2,857 Utah Medical Products shares in Q1 2020, an estimated $308K.
  • Oxford Asset Management first reported a position in Utah Medical Products in Q2 2017 and held it in 11 quarters.
  • Oxford Asset Management's Utah Medical Products position peaked at $1.71M in Q3 2018.
  • 90 funds tracked by Wall St. Rank held Utah Medical Products as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.